Procalcitonin as a diagnostic marker of ventilator‑associated pneumonia in cardiac surgery patients

Experimental and Therapeutic Medicine

Volumn 9, Issue 3, 2015, Pages 1051-1057

  Jiao, Jia ^a,b   Wang, Min ^a   Zhang, Jianfeng ^a   Shen, Kangjun ^a   Liao, Xiaobo ^a   Zhou, Xinmin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac surgery; Diagnostic marker; Procalcitonin; Ventilator associated pneumonia

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CARDIOVASCULAR DISEASE; CHEMOLUMINESCENCE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HEART SURGERY; HUMAN; LUNG DISEASE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; POSTOPERATIVE COMPLICATION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; THORAX RADIOGRAPHY; VENTILATOR ASSOCIATED PNEUMONIA; YOUNG ADULT;

EID: 84922022052     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2175     Document Type: Article

References (30)

1. Hortal J, Giannella M, Pérez MJ, et al: Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med 35: 1518-1525, 2009.
2. Vijarnsorn C, Winijkul G, Laohaprasitiporn D, et al: Postoperative fever and major infections after pediatric cardiac surgery. J Med Assoc Thai 95: 761-770, 2012.
3. Melsen WG, Rovers MM, Groenwold RH, et al: Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 13: 665-671, 2013.
4. Hortal J, Muñoz P, Cuerpo G, Litvan H, Rosseel PM and Bouza E; European Study Group on Nosocomial Infections; European Workgroup of Cardiothoracic Intensivists: Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care 13: R80, 2009.
5. Roeleveld PP, Guijt D, Kuijper EJ, Hazekamp MG, de Wilde RB and de Jonge E: Ventilator-associated pneumonia in children after cardiac surgery in The Netherlands. Intensive Care Med 37: 1656-1663, 2011.
6. Tamayo E, Álvarez FJ, Martínez-Rafael B, et al; Valladolid Sepsis Study Group: Ventilator-associated pneumonia is an important risk factor for mortality after major cardiac surgery. J Crit Care 27: 18-25, 2012.
7. Becker KL, Snider R and Nylen ES: Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36: 941-952, 2008.
8. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J and Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341: 515-518, 1993.
9. Riedel S: Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis 73: 221-227, 2012.
10. Rea-Neto A, Youssef NC, Tuche F, et al: Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 12: R56, 2008.
11. Sponholz C, Sakr Y, Reinhart K and Brunkhorst F: Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 10: R145, 2006.
12. Adib-Conquy M, Monchi M, Goulenok C, et al: Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock 28: 406-410, 2007.
13. Sinning JM, Scheer AC, Adenauer V, et al: Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J 33: 1459-1468, 2012.
14. American Thoracic Society; Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: 388-416, 2005.
15. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710, 1996.
16. Duflo F, Debon R, Monneret G, Bienvenu J, Chassard D and Allaouchiche B: Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 96: 74-79, 2002.
17. Oppert M, Reinicke A, Müller C, Barckow D, Freix U and Eckardt KU: Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation 53: 167-170, 2002.
18. Luyt CE, Combes A, Reynaud C, et al: Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 34: 1434-1440, 2008.
19. Hensel M, Volk T, Döcke WD, et al: Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 89: 93-104, 1998.
20. Amin DN, Pruitt JC and Schuetz P: Influence of major cardiopulmonary surgery on serum levels of procalcitonin and other inflammatory markers. Anaesth Intensive Care 40: 760-766, 2012.
21. Beghetti M, Rimensberger PC, Kalangos A, Habre W and Gervaix A: Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children. Cardiol Young 13: 161-167, 2003.
22. Meisner M, Rauschmayer C, Schmidt J, et al: Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 28: 1094-1102, 2002.
23. Jebali MA, Hausfater P, Abbes Z, Aouni Z, Riou B and Ferjani M: Assessment of the accuracy of procalcitonin to diagnose postoperative infection after cardiac surgery. Anesthesiology 107: 232-238, 2007.
24. Prat C, Ricart P, Ruyra X, et al: Serum concentrations of procalcitonin after cardiac surgery. J Card Surg 23: 627-632, 2008.
25. Meisner M, Tschaikowsky K, Palmaers T and Schmidt J: Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3: 45-50, 1999.
26. Haasper C, Kalmbach M, Dikos GD, et al: Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. Technol Health Care 18: 89-100, 2010.
27. Ramirez P, Garcia MA, Ferrer M, et al: Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 31: 356-362, 2008.
28. Hammer S, Fuchs AT, Rinker C, et al: Interleukin-6 and procalcitonin in serum of children undergoing cardiac surgery with cardiopulmonary bypass. Acta Cardiol 59: 624-629, 2004.
29. Denizot Y, Lorgeot V, Cornu E and Nathan N: Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation. Cytokine 10: 303-306, 1998.
30. Póvoa P: C-reactive protein: a valuable marker of sepsis. Intensive Care Med 28: 235-243, 2002.